SOURCE: Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc.

June 04, 2013 09:00 ET

Therapeutic Solutions International, Inc. Announces the Signing of a Letter of Intent With S4S (UK) Limited for Distribution Rights to Patented and FDA Cleared Sleep Appliance Hardware

OCEANSIDE, CA--(Marketwired - Jun 4, 2013) - Therapeutic Solutions International, Inc. (OTCQB: TSOI) announced today the signing of a Letter of Intent with S4S (UK) Limited for exclusive distribution rights for the United States to market U.S. Patented and FDA cleared titratable sleep appliance hardware.

"This letter of intent with TSI is one more forward step in our ever growing relationship," said Matt Everatt, Technical Director of S4S (UK) Limited, adding "we are very excited about TSI exclusively distributing our sleep appliance hardware in the U.S. and look forward to completing a definitive agreement."

Dr. Barry Glassman, VP of Education and Training, stated, "TSI's finalizing plans to enter the dental sleep market is exciting and totally consistent with our mission statement. By acquiring rights to this sleep appliance hardware, TSI enters the dental sleep market with an evidenced based technology that is competitively priced in a price sensitive market. I look forward to continuing teaching dental sleep concepts and the advantage both nationally and internationally to this appliance."

"Our alliance with S4S has provided us an opportunity to introduce a new product into the US marketplace," said Tim Dixon, CEO of TSI. Mr. Dixon added, "We have been working on this collaboration with S4S and look forward to a long and rewarding relationship. According to the American Academy of Dental Sleep Medicine 'More than 18 million Americans have sleep apnea, and many are not receiving treatment.' We intend to play a role in the treated and untreated with our Sleep Appliance hardware."

Oral appliances are a front-line treatment for snoring and mild to moderate obstructive sleep apnea. These small plastic devices fit in the mouth during sleep like a sports mouth guard or orthodontic retainer. Oral appliances help keep the airway open during sleep promoting adequate air intake. Oral appliances may be used alone or in combination with other treatments for sleep-related breathing disorders, such as weight management, surgery or CPAP.

Therapeutic Solutions International is also a global manufacturer of the chairside anterior midpoint stop appliance (AMPSA) devices marketed internationally under the trade names Migran-X® and AMPSA CS®, which have helped countless patients prevent debilitating migraine and tension headache pain, bruxism, clenching, grinding, and TMJ disorders. The Migran-X® and AMPSA CS® devices are the most effective non-drug US FDA cleared dental method of migraine prevention on the market today.

About Therapeutic Solutions International, Inc.

The Company's corporate website is Non-US dentists and physicians can order our AMPSA products at

Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at

Contact Information

  • For more information please contact:
    Therapeutic Solutions International, Inc.